Background-High-density lipoprotein cholesterol (HDLC) is a strong risk factor for atherosclerosis and is assumed to be under considerable genetic control. We aimed to identify gene regions that influence HDLC levels by a genome-wide association analysis in the population-based KORA (Cooperative Health Research in the Region of Augsburg) study. Methods and Results-In KORA S3/F3 (nϭ1643), we analyzed 377 865 quality-checked single-nucleotide polymorphisms (SNPs; 500K, Affymetrix, Santa Clara, Calif), complemented by the publicly available genome-wide association results from the Diabetes Genetics Initiative (nϭ2631) and by replication data from KORA S4 (nϭ4037) and the Copenhagen City Heart Study (nϭ9205). Among the 13 SNPs selected from the KORA S3/F3 500K probability value list, 3 showed consistent associations in subsequent replications: 1 SNP 10 kb upstream of CETP (pooled probability valueϭ8.5ϫ10 Ϫ27 ), 1 SNP approximately 40 kb downstream of LIPG (probability valueϭ4.67ϫ10 Ϫ10 ), both independent of previously reported SNPs, and 1 from an already reported region of LPL (probability valueϭ2.82ϫ10 Ϫ11 ). Bioinformatical analyses indicate a potential functional relevance of the respective SNPs. Conclusions-The present genome-wide association study identified 2 interesting HDLC-relevant regions upstream of CETP and downstream of LIPG. This draws attention to the importance of long-range effects of intergenic regions, which have been underestimated so far, and may impact future candidate-gene-association studies toward extending the region analyzed. Furthermore, the present study reinforced CETP and LPL as HDLC genes and thereby underscores the power of this type of genome-wide association approach to pinpoint associations of common polymorphisms with effects explaining as little as 0.5% of the HDLC variance in the general population. (Circ Cardiovasc Genet. 2008;1:10-20.)
H igh-density lipoprotein (HDL) particles exhibit multiple antiatherogenic effects, 1 and HDL cholesterol (HDLC) concentrations show a strong inverse correlation with the risk of coronary artery disease. 2 Epidemiological studies have highlighted the antiatherogenic function of HDLC and showed that an increase of 1 mg/dL in HDLC levels is associated with a 2% and 3% decrease in risk of coronary artery disease in men and women, respectively. 3, 4 The main function of HDL lies in its ability to remove cholesterol from peripheral tissue (eg, macrophages) and transport it to the liver or other tissues in need of large amounts of cholesterol. This complex process is called reverse cholesterol transport and is thought to represent the basis for the antiatherogenic properties of HDL. 1, 5 Furthermore, HDL has antioxidative properties due to associated antioxidative enzymes and expresses antiinflammatory activity in various pathways.
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In addition to the documented association of low HDLC states with elevated risk for coronary artery disease, high and therefore potentially protective HDLC states have also been reported. Although the pharmacological treatment and prevention of atherosclerosis during the past several decades has focused mainly on lowering low-density lipoprotein cholesterol levels, several pharmacological intervention strategies are under development that aim to increase HDLC levels. 4 For example, CETP deficiency is the basis for the development of new drugs to increase HDLC levels. 6 However, one of those drugs (torcetrapib) recently was shown to have side effects such as hypertension, which resulted in withdrawal of clinical trials. 7 If increasing HDLC levels or changing the quality of HDL particles indeed works to influence coronary artery disease, and if a main cause of the failure of torcetrapib was the lack of knowledge about cofactors that are required for functional HDL, the search for additional genes as potential new drug targets will be a major goal of future studies.
HDLC is under considerable genetic control, with heritability estimates of up to 80%. 8, 9 At least 10 candidate genes are reported to be associated with HDL concentrations, 6 but even more are involved in the pathways that regulate reverse cholesterol transport. 5 Genetic factors that influence HDLC plasma levels that have been confirmed by epidemiological studies include mutations in ABCA1, CETP, LPL, LIPG, LIPC, LCAT, SCARB1, and polymorphisms in the APOA1/ C3/A4/A5 gene cluster (for a systematic overview, see Table  1 and the online-only Data Supplement).
There are several advantages to analyzing HDLC as a quantitative phenotype in a representative population-based sample of subjects. The quantitative nature of the phenotype increases the power of the study considerably. The use of a general population sample reduces the number of subjects taking antilipidemic medication compared with patient groups. The KORA (Cooperative Health Research in the Region of Augsburg) study is of such a design, and the 500K Affymetrix single-nucleotide polymorphism (SNP) panel was applied to genotype a representative subset of the third KORA survey (KORA S3/F3 500K Study). The present analysis strategy was further complemented by the publicly available genome-wide association (GWA) study from the Diabetes Genetics Initiative (DGI; http://www.broad.mit.edu/ diabetes/scandinavs/), and initial GWA signals were replicated in the fourth KORA survey (KORA S4) and the Copenhagen City Heart Study. Together, this provides a set of strong epidemiological studies with which to investigate genetic SNP associations with HDLC levels on a genomewide scale by use of a hypothesis-free approach complemented by a priori knowledge of HDLC candidate genes.
Methods

Study Steps and SNP Selection Strategies
We conducted a GWA study with subsequent replication to avoid false-positive findings. Figure 1 illustrates the 3 steps (a GWA analysis, then a first and a second replication level). We implemented 2 parallel SNP selection strategies for follow-up in the replication levels: for the first strategy we analyzed the Affymetrix 500K SNPs in 1643 subjects from the population-representative KORA S3/F3 cohort 10 with HDLC values available (measured during the F3 follow-up) and selected the best SNPs top down from the list of probability values Ͻ10 Ϫ4 , as well as SNPs representative of known HDLC candidate genes with PϽ10 Ϫ3 for replication in 4037 subjects *Strength of evidence from epidemiological studies: ϩ for each study with Ն500 subjects, o for each study with 200 to 500 subjects. Because of the strong evidence for CETP, LPL, LIPC, and ABCA1, only studies with Ն500 subjects are listed.
†Supplementary references are provided in the Data Supplement. from KORA S4. We later added the DGI, which included 1348 control subjects and 1283 patients with type 2 diabetes mellitus (genotyped by Affymetrix 500K) and which was made publicly available in April 2007: for the second strategy we used the HDLC GWA results from both KORA S3/F3 and DGI and selected SNPs with probability values Ͻ0.01 in both, as well as estimates pointing in the same direction for replication in KORA S4. The significant SNPs from gene regions not yet reported to be associated with HDLCthat emerged from either selection strategy were planned to be carried forward to the second replication level, the Copenhagen City Heart Study (nϭ9205). A detailed description of the studies and genotyping methods is provided in the Data Supplement.
Statistical and Bioinformatical Analysis
GWA Analysis
For the KORA S3/F3 500K sample, we used linear regression, applying an additive genetic model adjusted for age and sex to test each SNP for association with the quantitative phenotype HDLC. Details are provided in the Data Supplement. For the DGI sample, we used the publicly available probability values and estimates derived by linear regression adjusted for age, age 2 , sex, body mass index, study center, and diabetes status.
Replication Sample Analysis
For each SNP, we applied linear regression models adjusted for age and sex that incorporated the additive genetic effect model.
Imputed SNP Data
For gene regions of specific interest, we used imputed SNP data with the MaCH approach and accounted for imputation uncertainty in the association analysis (see Data Supplement for details).
Bioinformatical Analysis
To indicate the potentially functional relevance of regions identified by our GWA analysis, we investigated evolutionary conservation between species and searched for possible regulatory elements such as known microRNAs, predicted transcription factor binding sites, known enhancer regions, ENCODE (ENCyclopedia Of DNA Elements) transcripts, or RNA secondary structures. For this purpose, we also used the ESPERR (Evolutionary and Sequence Pattern Extraction through Reduced Representations) regulatory potential value (for details, see Data Supplement).
Candidate-Gene SNP Identification
Before GWA data analysis, we searched the literature for candidate genes reported in epidemiological studies to be associated with HDLC. If at least 1 SNP of a gene was reported at least twice for association in a large (Ͼ500 subjects) study, the gene was considered an HDLC candidate gene.
The authors had full access to the data and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Characteristics of Study Participants
The participants of the 3 involved population-based studies (KORA S3/F3, KORA S4, and the Copenhagen City Heart Study) displayed very similar characteristics (Data Supplement Table I ). With a -inflation factor of 0.99, there was clearly no indication of population stratification in the KORA S3/F3 500K sample.
Literature-Reported HDLC Candidate Genes
Our literature research revealed 10 genes with SNPs previously reported to be associated with HDLC in at least 2 substantially large studies (Table 1) . Epidemiological evidence was strong for CETP, LPL, LIPC, and APOA5. It was less strong or sparse for LIPG, LCAT, APOA1, APOC3, SCARB1, and ABCA1 in contrast to clear functional results or observations in patients with gene mutations with pronounced influences on the gene product. Figure 2 summarizes the results of the main KORA S3/F3 500K analysis. In particular, the quantile-quantile plot illustrates observed significant associations beyond those expected by chance. The specific results for all SNPs with PϽ10 Ϫ4 and for additional SNPs from HDLC candidate genes with PϽ10 Ϫ3 are summarized in Data Supplement Table IIIA . We detected 54 SNPs with PϽ10 Ϫ4 (38 expected by chance), including several SNPs within or around 4 of the 10 HDLC candidate genes, namely, CETP, LPL, LIPG, and SCARB1.
Results of KORA S3/F3 GWA Analysis
From this probability value-ranked "hit list," we selected 4 SNPs representative of the 4 candidate genes and 12 SNPs top down from as yet unreported HDLC genes (until PϾ2.0ϫ10 Ϫ5 ) and successfully genotyped 13 of these 16 SNPs in the replication sample KORA S4. The minor allele frequencies of all SNPs were consistent in KORA S3/F3 and KORA S4. We found 3 (CETP, LPL, and LIPG) of the 4 Figure 2 . GWA analysis in KORA S3/F3 (nϭ1643). A, Probability values from linear regression analysis after application of an additive genetic model adjusted for age and sex, with color coding for SNPs in HDLC candidate genes Ϯ15 kb (red), for top hits in KORA S3/F3 GWA (blue), and for SNPs with PϽ0.01 in both KORA S3/F3 and DGI GWA analyses (turquoise). B, Quantile-quantile plot for these probability values. E Indicates observed association above expected (red line).
HDLC candidate-gene SNPs to be highly significantly associated with HDLC, whereas the SCARB1 SNP did not replicate ( Table 2 ). The later-added DGI estimates for these 4 SNPs were consistent with KORA S4 estimates, and pooled probability values reached genome-wide significance for the SNP near CETP (8.5ϫ10 Ϫ27 ), LPL (2.82ϫ10 Ϫ11 ), and LIPG (4.67ϫ10 Ϫ10 ). All effects were consistent across sex and 10-year age groups (data not shown).
None of the 9 SNPs in the as yet unreported HDLC genes yielded significant associations at the 0.05/9ϭ0.006 significance level (Data Supplement Table IIIB) . Because the UBXD2 SNP rs16831992 showed strong effects in the same direction in both GWA samples, this SNP was selected for additional genotyping in the Copenhagen City Heart Study, but it did not replicate (Data Supplement Table IIIB 
A Closer Look at the Gene Regions of Interest by Use of the Imputed SNP Panel
To clarify whether the identified SNP hits (or highly correlated SNPs) were reported previously or whether these SNPs pinpoint new independent gene regions, we used the imputed SNP data to investigate linkage disequilibrium (LD) and block structure, as well as the independence of SNP associations from previously reported associations (see Data Supplement, Statistical Methodology). Figures 3A through 3C depict the probability values for HDL association, with color coding of the correlation of SNPs with the top KORA S3/F3 500K hits and marking of the reported and replicated SNPs. These figures also elucidate the location of neighboring genes and block structure.
From Figure 3A , it can be seen that the CETP 500K top hit (rs1800775) was already reported to be associated with Four SNPs were selected from within or around the 4 previously reported HDLC candidate genes for replication in KORA S4 and augmented by results from DGI. All SNPs together explained 4.09% of the HDLC variance in KORA S3/F3 and 2.42% in KORA S4.
*P ranking of SNP according to KORA S3/F3 GWA. †All genes with at least 2 large (Ͼ500 subjects) studies reporting an HDLC association and with SNPs showing P values Ͻ10 Ϫ3 in KORA S3/F3 GWA. ‡SNP with the highest P value in the KORA S3/F3 GWA, except for CETP and SCARB1, for which we took the second-best SNP for optimal genotyping conditions in the iPLEX.
§␤-Estimate for change in mean HDLC levels per additional minor allele. ʈP from additive model without adjustment for multiple testing; combined P values for all studies were calculated with the weighted Z-method. ¶Calculations in KORA S3/F3 were based on HDLC measurements in KORA F3. When using KORA S3 HDLC measurements (10 years before F3 measurements), we observed similar results; no association was found for 10-year changes in HDLC levels.
#Genotype frequencies and Hardy-Weinberg equilibrium are not available for the DGI Study; however, an SNP had to pass Hardy-Weinberg equilibrium with PϾ10
Ϫ6
to be included in the analysis. HDLC. In contrast, the second-best 500K SNP hit (rs9989419) appeared to be independent from the already known rs1800775, which is underscored by the lack of correlation (r 2 Ͻ0.20) between the 2 markers and the fact that the rs9989419 association remained virtually unchanged after adjustment for rs1800775. In fact, rs9989419 was independent from all other SNPs (r 2 Ͻ0.3; see more detailed LD plot in Data Supplement Figure I and the LD bin in Data (Figure 3B ), most of the highly associated SNPs were correlated with each other and with the 3 reported SNPs (rs328, rs320, and rs13702). For LIPG (Figure 3C ), the observed significant associations were for SNPs approximately 40 to 70 kb downstream of LIPG, and thus, we extended the analyzed region to 225 kb downstream to also include the neighboring gene ACAA2. Three SNPs among the genotyped and imputed SNPs were reported in the literature. All 3 were located in the gene, and none were correlated (r 2 Ͻ0.20) to the LIPG 500K top hits (rs7240405, rs2156552, rs1943981, and rs4939883; all correlated with each other). Most importantly, adjustment of the LIPG 500K top hits for the reported SNPs did not change the observed association. This may pinpoint an HDLC-relevant gene region 40 to 70 kb downstream of LIPG outside the previous focus of candidategene studies.
HDLC Candidate-Gene Regions Including Imputed SNP Data
To elucidate the coverage of the HDLC candidate genes among the genotyped and imputed SNPs and to highlight the number of "reinforced" HDLC candidate genes, Data Supplement Table VI 
Bioinformatical Analysis on Functional Relevance
For detailed results of our bioinformatical analysis, see the Data Supplement, including Figures III through VII and Tables VII and VIII. No known regulatory regions, promoterspecific sequences, or noncoding RNAs were found by Genomatix software (Ann Arbor, Mich) within the regions that showed the strongest associations in the present GWA analysis; thus, we focused on searching for putative, as yet unknown regulatory sites by analyzing the conservational pattern and ESPERR scores in these regions.
Because CETP activity is not present in most mammals, it was not surprising that conservation analysis was inconclusive. The region around rs9989419 approximately 10 kb upstream of CETP and located in a recombination hot spot between LD blocks was found to have a high regulatory potential based on ESPERR scores.
For LIPG, the region with our strongest associations (approximately 40 to 70 kb downstream of the gene) showed several conserved regions. One additional short, Ϸ600-bp highly conserved region with a high regulatory potential was seen immediately upstream of this region. Five transcription factor binding sites were predicted for this short region, 2 of which were binding sites for peroxisome proliferator-activated receptor factors, which have repeatedly been reported to be involved in cholesterol metabolism. Furthermore, a binding site for HNF1 was detected even further downstream, within the region with the strongest association in the present study.
Although for LPL, the evidence for intergenic conservation, regulatory potential, and transcription factor binding sites was generally less pronounced than for LIPG, we found that our best hit, rs17482753, was located in a 2-kb conserved region approximately 6 kb downstream of the gene. Furthermore, 2 databases predicted that the minor allele of rs3289 created a microRNA-145 binding site, which was shown to be strongly expressed in adipose tissue by mouse expression profiles.
Discussion
On the basis of 2 GWA scans for HDLC that included a total of 4274 subjects and subsequent replication of the highestscoring SNPs in an additional population-based sample of 4037 subjects, we identified an HDLC-relevant gene region 40 to 70 kb downstream of the LIPG gene not yet indicated by any candidate-gene studies. Furthermore, we pinpointed a potential functional relevance of a polymorphism approximately 10 kb upstream of the CETP gene, which was associated with HDLC independently of the numerous already reported CETP SNPs. Although CETP and, to a lesser extent, LIPG are 2 well-described genes that modulate HDLC in the general population, the present results draw attention to the importance of independent intergenic regions, which has been underestimated thus far.
Findings Regarding Known Candidate Genes
The present study can be considered as proof of principle that GWA analyses successfully identify genes for complex quantitative phenotypes such as HDLC levels in a populationbased design. A thorough literature search for genetic epidemiological studies before the present GWA analysis identified 10 reported HDLC candidate genes. We were able to "reinforce" 2 of these genes: CETP reached genome-wide significance in our GWA analysis, and several LPL SNPs exhibited strong "experiment-wise" significance when the replication data were added. The other reported HDLC candidate-gene SNPs were not covered by SNPs on the 500K chip (LCAT), or none (LIPC, LIPG, APOA5, APOA1, and APOC3) or just 2 (ABCA1) of the SNPs reported in the literature were covered by the 500K chip, a well-known limitation of this chip (Data Supplement Table VI) . When using the HapMap-based imputed SNP panel within and around the gene regions of interest, we found minor associations with all of these genes, although without statistical significance given the multiple tests performed.
A recent meta-analysis that combined 3 genome-wide scans totaling 8816 individuals identified 5 of the 10 candidate genes (CETP, LPL, LIPC, LIPG, and ABCA1) with genome-wide significance. 11, 12 This is in accordance with the power considerations of the present study, which indicated that the present KORA S3/F3 GWA analysis had 80% power to detect SNPs explaining 2% of the variance in HDLC on a genome-wide significance level (1.7ϫ10 Ϫ7 ), which corresponded to an HDLC difference of 3.9 mg/dL per minor allele with 25% frequency (eg, CETP effect). The GWA analysis power was only 20% without the replication sample but increased to 100% (92%) to detect an effect of 1% (0.5%) or a 2.8 (2.0)-mg/dL difference in HDLC for 25% minor allele frequencies at a 1-sided significance level of 0.002 (assuming 25 independent tests) when the KORA S4 replication sample was added. Because the recent meta-analyses [11] [12] [13] were based mainly on disease-ascertained subjects, the results of a population-based study in an ethnically homogeneous sample (south German whites) are needed to confirm these findings and extend them by providing an estimated impact on the general population HDL variance of 1.4% to 0.5% per SNP (Table 2) .
New Intergenic Regions of Interest
The most important observation of the present study was the fact that strong association signals in CETP, LPL, and LIPG were observed for SNPs in regions hitherto regarded as "intergenic," up to 70 kb downstream of LIPG and LPL and 10 kb upstream of CETP. This is particularly remarkable because the usual current candidate-gene studies focus on SNPs within the gene Ϯ5 kb. Although the downstream LPL SNPs in the present study showed some correlation with previously reported SNPs within the gene, LIPG signals in the present study were completely independent of SNPs within the gene or any SNP reported previously in candidategene studies ( Figures 3B and 3C) .
Although LIPG was an HDLC candidate owing to our literature search criteria, the epidemiological evidence from candidate-gene studies was sparse, and previously reported SNPs within the LIPG gene did not show an association in the present study. This could be due to rare genetic variants that were undetectable by the present GWA approach explaining considerably less than 0.5% of the HDLC variance, but it could also be due to long-range mechanisms of SNPs in intergenic regions that have not been studied to date.
The identified CETP SNP 10 kb upstream was independent of the numerous SNPs reported in candidate-gene studies and was even located in a recombination hot spot, which strongly supports this region as an independent locus ( Figure 3A ; Data Supplement Figure I ). These results are in line with a recent dense genotyping project in the CETP region that showed that SNPs further upstream of the promoter region have an important impact on HDLC levels. 14 The present results clearly show that this effect on HDLC is entirely independent of the other SNPs investigated.
A detailed bioinformatical analysis using various tools supported the possible functional relevance of the regions with the strongest GWA association signals. Besides their influence on transcription factor binding sites, we observed effects of some SNPs on putative microRNA binding sites. A tool with a reported accuracy of 94% indicated a potential for yet unknown regulatory elements. Interestingly, a recent study showed strong effects of transcription factor binding sites in intergenic regions on adjacent genes by interfering, respectively competing, with their transcription mechanism without being directly involved in regulation. 15 An in-depth functional analysis of these remote-controlled regulatory mechanisms is needed to clearly define which SNP may be functional. A similar example has been reported for chromosomal region 9p21, which was shown to be associated with myocardial infarction and type 2 diabetes mellitus (for review, see Kronenberg 16 ). SNPs with the most significant signals were located Ͼ100 kb upstream of the cyclindependent kinase inhibitors CDKN2A and CDKN2B, which supports either long-range effects on 1 of these genes or the influence of a gene not yet annotated. This supports the present observation of the relevance of intergenic regions and calls for future functional studies to address this issue.
Consequences for Candidate-Gene Association Studies
The relevance of genetic variation well beyond the gene might have far-reaching consequences for candidate-gene association studies in general. It is conceivable that in the past, plausible candidate genes have been dropped prematurely when no association between intragenic variation and the investigated phenotypes was observed. In particular, the present example of LIPG impressively demonstrates that genetic variation far downstream of the gene can show a pronounced association with a phenotype. In addition, bioinformatical analyses support these regions as potential regions of functional relevance. If these regions are not considered, and the variation located there is not in strong LD with intragenic variation, an association would be missed. It must be determined how far such long-range effects can reach, so that a strategy for the investigation of future candidate-gene regions can be developed. A greater weighting for intragenic regions in previous candidate-gene studies would result in a biased search of phenotype-influencing gene regions and should probably be avoided.
In line with these observations, the GWA approach thus evolves as the "better" candidate gene study, because it enables a much more comprehensive analysis of all known candidate genes, with ad libitum extension beyond gene boundaries and comparability across studies. Previously, candidate-gene studies each investigated different SNPs with different HDLC measurements and often different analysis models, and most of the studies had a strong focus on the promoter and intragenic regions of these genes.
Study Strengths and Limitations
We consider it a major strength of the present study that it is the first general-population-based GWA study on HDLC, which means it has less risk of confounding due to population stratification than ethnically more heterogeneous samples and less risk of loss of power due to medicated participants, as in case-control studies. The present study design also enables the calculation of SNP-explained HDLC variance as it can be expected in the general German population. A great advantage of GWA studies is that they can guide costly and laborious functional studies not only toward new potential gene regions, such as the intergenic regions mentioned here, but also toward specific polymorphisms that may appear to be independent of previously known polymorphisms and that may be of potential interest for functional clarification, such as the CETP rs9989419.
It may be considered a limitation that the effect sizes in the present study are modest, together explaining approximately 2.4% to 4.1% of the variance of HDLC in the general population (Table 2) ; however, the variants reported here were common, with minor allele frequencies of 10% to 40%, and thus affect a substantial proportion of the population. Furthermore, modulation of HDLC concentrations by certain SNP variants was found in young individuals as frequently as in older individuals, which pinpoints the potential for early prevention. Finally, numerous genetic effects are obviously still undetected given the estimated heritability of HDLC of up to 80%. 8, 9 The present study and others [11] [12] [13] appear to indicate that there are numerous small effects, and these may be detected through future meta-analyses of several GWA studies for more common polymorphisms and through analysis of rare variants, as recently demonstrated impressively. 17 Because of the population-based nature and ethnic homogeneity of the studies, studies such as the KORA S3/F3 may be of great value for future large GWA meta-analyses, which will be mandatory to identify these small effects. Even if small, any genetic effect will tremendously enhance our knowledge of the mechanisms of HDLC-level modulation. This may also impact future drug development, which may heavily rely on our understanding of the entire HDLC metabolic network to avoid the types of side effects observed recently. 7 
Conclusions
The present GWA study identified 2 HDLC-relevant regions downstream of LIPG and upstream of CETP that might be of functional relevance. This may draw the attention of future genetic studies to the long-range effects of intergenic regions, which have been neglected so far.
CLINICAL PERSPECTIVE
High-density lipoprotein cholesterol (HDLC) is a strong risk factor for atherosclerosis and is assumed to be under considerable genetic control. We applied the hypothesis-free approach of a genome-wide association analysis to identify gene regions that influence HDLC levels. On the basis of 2 genome-wide association scans for HDLC that included a total of 4274 subjects and subsequent replication of the highest-scoring SNPs in a further population-based sample of 4037 subjects, we identified an HDLC-relevant gene region 40 to 70 kb downstream of the LIPG gene not yet indicated by any candidate-gene studies. Furthermore, we pinpointed the potential functional relevance of a polymorphism approximately 10 kb upstream of the CETP gene, which was associated with HDLC concentrations independently of the numerous already reported CETP SNPs. Although CETP and, to a lesser extent, LIPG are 2 well-described genes that modulate HDLC in the general population, our results draw attention to the importance of independent intergenic regions, which has been underestimated to date. The relevance of genetic variation far outside the gene might have far-reaching consequences for candidate-gene association studies in general. It is conceivable that plausible candidate genes have been dropped prematurely in the past when no association between intragenic variation and the investigated phenotypes was observed. Recent studies show that regulatory regions for particular genes can sometimes be megabases away from the studied gene, and our bioinformatical analysis suggested several regions with high regulatory potential in the upstream and downstream regions of the mentioned genes. Therefore, a genome-wide association approach evolves as the "better" candidate-gene study, because it enables a much more comprehensive analysis with an ad libitum extension beyond gene boundaries. 
Supplementary Material to
Literature-reported HDLC Candidate Genes
The literature search for genes previously reported for association with HDLC was performed in PubMed using search terms such as "(polymorphism OR genetic OR mutation) AND HDL". Results were complemented by knowledge of the lipidexperienced investigators of this study. A gene was considered an HDL candidate gene if at least two substantially large studies (>500 subjects) reported an association of genetic variation within the particular gene with HDL cholesterol levels.
It should be noted that identifying the precise rs numbers was very tedious if not impossible as rs numbers were often lacking or mistakenly reported and in some of these cases we were only able to derive rs numbers by combining literature reports with HapMap and NCBI or other databases.
The following literature references (Supplementary References, SR) were the basis of our literature search and summaries are provided in 
Study Populations and Recruitment
Genotyping
For genome-wide SNP genotyping, the two chips (Sty I and Nsp I) of the The method of 5' nuclease allelic discrimination (Taqman) assays was also applied for genotyping in the Copenhagen City Heart Study.
For the statistically imputed SNP panel, only SNPs with minor allele frequency >1% and an imputation predicted r²>0.6, which provides a measure of certainty in the imputed genotype ranging from zero to unity, were considered further. Figure  3C ). 
Statistical Methodology (Power Considerations
,
Bioinformatic Analysis for Functional Relevance
In order to find indications for potential functional relevance of the regions highlighted by this GWA study, several approaches were followed: (1) the evolutionary conservation of this region was evaluated using the VISTA Genome Browser captures also other signals such as GC content and has shown to be able to detect not only classical TFBS, but also other regulatory elements such as enhancer activities or DNAse I hypersensitive sites. The reported accuracy in discriminating neutral from regulatory DNA stretches is 94% 10 .
Endothelial lipase (LIPG)
The strongest associations for LIPG with HDLC levels were found by our GWA 
Lipoprotein lipase (LPL)
The strongest associations in our GWA analysis for LPL were found in a region spanning from exon 6 to 70 kb downstream of the gene (corresponds approximately to the position 19,857,000 -18,939,000 on chromosome 8). The large size of this region can be partly accounted to the strong LD-structure in this region (see also Figure 3B of the main document).
Although the intergenic conservation (Supplementary Figure S5) as well as detected regulatory potentials and number of TFBS (Supplementary Figure S6) were generally less pronounced than for LIPG, we interestingly found that our best hit rs17482753 
Cholesteryl ester transfer protein (CETP)
Since CETP activity is not present in most mammals, conservation analysis was not conclusive. The analysis for possible regulatory regions using the UCSC browser is shown in Supplementary Figure S7 .
Since the upstream region of genes is commonly regarded as target for transcription factors, we investigated the possibility that a SNP may affect a TFBS using the Genomatix Software suite. While the rs1800775 did not reveal any biologically plausible consequences, the minor allele of rs17368435 appeared to create a binding site for the hepatic factor HNF4. Since the latter SNP is located 1247bp upstream of the CETP, which is predominantly expressed in the liver, a functional consequence of this SNP is conceivable. The strongest associations for CETP in our GWA analysis 
